Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic equivalence study of Salmeterol/Fluticasone DPI HEXAL versus Seretide 100 Accuhaler in pediatric moderate persistent asthma
2007-005630-36Phase 3Completed
- Sponsor
- Hexal AG
- Start
- Apr 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of salmeterol and fluticasone propionate in asthma (2 arms), sponsored by Hexal AG. Primary endpoints: Absolute change in FEV1 and AUC0-4 of serial FEV1. Started Apr 2009; status: completed.
02
Drugs
salmeterolfluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-005630-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005630-36.